| |
| |
|
| Insider
Information: |
Conroy Kevin T |
| Relationship: |
|
| City: |
Madison |
| State: |
WI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,204,819 |
|
|
Indirect Shares
|
238,579 |
|
|
| Direct
Value |
$49,939,351 |
|
|
|
Indirect Value
|
$10,242,196 |
|
|
| Total
Shares |
1,443,398 |
|
|
| Total
Value |
$60,181,547 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -100.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exact Sciences Corp |
EXAS |
|
2024-05-01 |
1,156,191 |
2024-05-01 |
238,579 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2022-08-12 |
0 |
2018-07-02 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2023-03-06 |
22,968 |
2021-02-14 |
0 |
Premium* |
|
|
Cm Life Sciences Ii Inc. |
SLGC |
Director |
2021-09-01 |
25,000 |
2021-09-01 |
0 |
Premium* |
|
|
Align Technology Inc |
ALGN |
|
2024-05-22 |
660 |
2024-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
196 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,374 |
1,199,994 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,374 |
1,234,731 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-28 |
4 |
AS |
$61.12 |
$636,626 |
D/D |
(10,416) |
1,207,306 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2016-01-04 |
4 |
AS |
$8.72 |
$93,740 |
D/D |
(10,750) |
346,869 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2019-03-11 |
4 |
AS |
$87.21 |
$979,129 |
D/D |
(11,227) |
938,526 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2014-07-25 |
4 |
AS |
$15.99 |
$181,263 |
D/D |
(11,336) |
145,563 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2015-07-27 |
4 |
AS |
$24.04 |
$273,719 |
D/D |
(11,386) |
257,335 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2019-12-16 |
4 |
OE |
$13.96 |
$199,992 |
D/D |
11,440 |
950,466 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2018-03-12 |
4 |
AS |
$52.19 |
$598,091 |
D/D |
(11,459) |
882,439 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-22 |
4 |
AS |
$59.78 |
$691,356 |
D/D |
(11,565) |
1,241,429 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-06-01 |
4 |
AS |
$111.00 |
$1,374,624 |
D/D |
(12,384) |
745,112 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-03-31 |
4 |
A |
$1.15 |
$14,999 |
D/D |
13,043 |
43,120 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,181 |
1,295,887 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2020-02-27 |
4 |
AS |
$80.27 |
$1,113,746 |
D/D |
(13,875) |
982,138 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2022-03-01 |
4 |
AS |
$76.69 |
$1,096,590 |
D/D |
(14,299) |
930,984 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2022-02-15 |
4 |
AS |
$79.55 |
$1,146,236 |
D/D |
(14,409) |
878,694 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2023-02-15 |
4 |
AS |
$65.59 |
$958,729 |
D/D |
(14,617) |
1,189,620 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
14,775 |
22,968 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2024-02-15 |
4 |
AS |
$61.43 |
$908,611 |
D/D |
(14,791) |
1,224,357 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President & CEO |
• • – |
2010-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,288 |
24,288 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-17 |
4 |
AS |
$142.66 |
$2,257,595 |
D/D |
(15,825) |
792,460 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2019-02-25 |
4 |
AS |
$90.55 |
$1,485,036 |
D/D |
(16,400) |
903,936 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2011-12-31 |
4 |
D |
$8.12 |
$133,249 |
D/D |
(16,410) |
62,218 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2012-12-31 |
4 |
D |
$10.59 |
$173,782 |
D/D |
(16,410) |
86,770 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-24 |
4 |
AS |
$136.30 |
$2,238,046 |
D/D |
(16,420) |
810,365 |
0 |
% |
|
196 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
